-
07/13/2017
Licensing Agreement for Marketing Rights to Infliximab BS for I.V. Infusion 100mg “AYUMI”
-
06/19/2017
Consolidated Financial Results for the Fiscal Year Ended March 31, 2017
読む Consolidated Financial Results for the Fiscal Year Ended March 31, 2017
-
05/30/2017
Notice of the 53rd Ordinary General Meeting of Shareholders
読む Notice of the 53rd Ordinary General Meeting of Shareholders
-
05/10/2017
Consolidated Financial Results for the Fiscal Year Ended March 31, 2017 Results Settlement of Accounts Supplementary Material (Apr.1 2016 to Mar.31 2017 )
-
02/28/2017
Consolidated Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2017
読む Consolidated Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2017
